Market Overview

Mirum Pharmaceuticals Opens Below IPO Price


Mirum Pharmaceuticals (NASDAQ: MIRM) made its public debut Thursday morning, opening at $13 after being priced at $15 per share.

The shares are listed on the Nasdaq and trading under the symbol MIRM.

Mirum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Invest in IPO shares before the stock hits the market with ClickIPO. Check it out here

Citigroup, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering. Raymond James is acting as lead manager. Roth Capital Partners is acting as co-manager.

Related Links:

Mirum Pharmaceuticals IPO: What You Need To Know

Owl Rock Capital Opens Above IPO Price

Posted-In: News IPOs


Related Articles (MIRM)

View Comments and Join the Discussion!

Mid-Day Market Update: Crude Oil Down 2.9%; Co-Diagnostics Shares Spike Higher

FMCSA To Delay Compliance Deadlines For Driver Training Rule